Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)
A completed clinical trial update for Optima CAD evaluating optimal mechanical evaluation in patients with heart failure and ischemic cardio…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Prognostic Indicators as Provided by the EPIC ClearView
A completed clinical trial update from EPIC ClearView describing prognostic indicators across several conditions.
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Sodium Management in Acute and Chronic Heart Failure
A completed clinical trial update examining sodium management in acute and chronic heart failure.
-
FDA approval · 2011-11-18FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., authorizing changes to the product's labeling. …
-
CLINICAL_TRIALS research · 2011-11-16Clinical Trial Update: The Epidemiology of Ventricular Assist Device-Related Infections
This clinical trial update analyzes the epidemiology of ventricular assist device-related infections in patients with congestive heart failu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Linox Smart S DX PME/Master Study [Phase 4]
Phase 4 PME/Master Study for Linox Smart S DX has completed. The trial evaluated ICD indications and was sponsored by Biotronik.
-
FDA approval · 2011-11-14FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp., corresponding to a labeling update …
-
FDA approval · 2011-11-14FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for LANOXIN (digoxin) from Covis Pharma US, Inc., likely resulting in labeling updates for the produ…
-
FDA approval · 2011-11-14FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for hydrochlorothiazide submitted by Exelan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Study of Oral PG-116800 Following a Heart Attack [Phase 2]
Phase 2 trial of oral PG-116800 in patients after a heart attack has completed and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead [NA]
Results from a safety and efficacy study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead in heart failure patients have been compl…
-
FDA approval · 2011-10-17FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for PERINDOPRIL ERBUMINE from Aurobindo Pharma Limited (ANDA) to market the generic product.
-
FDA approval · 2011-10-13FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc., approving a generic hydrochlor…
-
CLINICAL_TRIALS research · 2011-10-06Clinical Trial Update: Viability and Cardiac Resynchronization Therapy [NA]
Clinical trial update on viability and cardiac resynchronization therapy for heart failure due to ischemic cardiomyopathy.
-
CLINICAL_TRIALS research · 2011-10-05Clinical Trial Update: Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
This clinical trial update reports on the potential utility of brain natriuretic peptide (BNP) as a biomarker in ICU patients with type IV c…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Use of Beta-agonists in Stable Severe Congestive Heart Failure [NA]
This clinical trial update reports on the use of beta-agonists in stable, severe congestive heart failure, including patients with ischemic …
-
CLINICAL_TRIALS withdrawal · 2011-09-30Clinical Trial Update: An-Art Study: Atrioventricular (AV) Node Ablation in Cardiac Resynchronisation Therapy [EARLY_Phase 1]
An early-phase clinical trial evaluating AV node ablation in cardiac resynchronisation therapy for Congestive Heart Failure was withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: CONTAK RENEWAL 3 AVT [Phase 3]
Phase 3 clinical trial CONTAK RENEWAL 3 AVT by Boston Scientific has completed. The study investigated effects in heart failure and atrial f…
-
FDA approval · 2011-09-26FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Congestive Heart Failure Outreach Program [Phase 4]
Phase 4 clinical trial update indicating the Congestive Heart Failure Outreach Program sponsored by the University of Alberta has completed.
-
FDA approval · 2011-09-22FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA issued a supplemental approval for Torsemide from Rising Pharma Holdings, approving a generic torsemide product.
-
FDA approval · 2011-09-21FDA Approved: TORSEMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for torsemide from Teva Pharmaceuticals USA, Inc. This approval pertains to a supplemental submissio…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Aldosterone Antagonism in Diastolic Heart Failure [Phase 4]
Phase 4 clinical trial update evaluating aldosterone antagonism for diastolic heart failure; the US Department of Veterans Affairs-sponsored…
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD [NA]
Completed clinical trial evaluating pulmonary function, prevalence of chronic obstructive pulmonary disease, and systemic inflammation in pa…
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: PRISM Cardiac Resynchronisation Therapy (CRT) Randomised Controlled Trial [Phase 2, Phase 3]
This entry reports a Phase 2/Phase 3 randomized trial evaluating cardiac resynchronisation therapy for heart failure. It is sponsored by Guy…